RNF6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.090200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.417600E-01
Normal-vs-Stage2
9.738800E-01
Normal-vs-Stage3
1.172630E-01
Normal-vs-Stage4
4.820400E-01
Stage1-vs-Stage2
1.528800E-01
Stage1-vs-Stage3
6.842500E-03
Stage1-vs-Stage4
7.308400E-01
Stage2-vs-Stage3
7.900200E-02
Stage2-vs-Stage4
4.028000E-01
Stage3-vs-Stage4
3.788300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.373400E-01
Normal-vs-AfricanAmerican
7.587200E-01
Normal-vs-Asian
8.794800E-01
Caucasian-vs-AfricanAmerican
6.694600E-01
Caucasian-vs-Asian
6.800200E-01
AfricanAmerican-vs-Asian
5.308800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.114000E-01
Normal-vs-Female
8.978800E-01
Male-vs-Female
8.758600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.741600E-01
Normal-vs-Age(41-60Yrs)
6.275000E-01
Normal-vs-Age(61-80Yrs)
9.150800E-01
Normal-vs-Age(81-100Yrs)
8.188600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.258800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.018200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.904000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.257500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.155600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.603200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.356200E-01
Normal-vs-Daily Drinker
5.578800E-01
Normal-vs-Weekly Drinker
8.877600E-01
Normal-vs-Occasional Drinker
4.514800E-01
Normal-vs-Social Drinker
7.752400E-01
Non Drinker-vs-Daily Drinker
9.151400E-01
Non Drinker-vs-Weekly Drinker
4.722000E-01
Non Drinker-vs-Occasional Drinker
6.061600E-03
Non Drinker-vs-Social Drinker
2.361800E-01
Daily Drinker-vs-Weekly Drinker
4.814800E-01
Daily Drinker-vs-Occasional Drinker
1.300280E-02
Daily Drinker-vs-Social Drinker
2.293000E-01
Weekly Drinker-vs-Occasional Drinker
1.432780E-01
Weekly Drinker-vs-Social Drinker
4.636200E-01
Occasional Drinker-vs-Social Drinker
8.472600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.247220E-01
Normal-vs-Grade 2
1.208070E-02
Normal-vs-Grade 3
1.445610E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.949000E-01
Grade 1-vs-Grade 3
4.429400E-01
Grade 1-vs-Grade 4
1.247220E-01
Grade 2-vs-Grade 3
8.226800E-01
Grade 2-vs-Grade 4
1.208070E-02
Grade 3-vs-Grade 4
1.445610E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.155200E-01
Normal-vs-NonDiabetic
9.038400E-01
Diabetic-vs-NonDiabetic
8.226500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.564800E-01
Normal-vs-NoPancreatitis
9.366000E-01
Pancreatitis-vs-NoPancreatitis
1.527600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.267600E-01
Normal-vs-N1
9.778600E-01
N0-vs-N1
4.260400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.443000E-01
Normal-vs-TP53-NonMutant
7.081800E-01
TP53-Mutant-vs-TP53-NonMutant
5.909800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
